RRC News Today: Stay Updated with the Latest Range Resources Corporation News in Real Time
Find RRC news now at Meyka AI. Stay informed with the latest{" "} Range Resources Corporation stocks updates, including price news, market analysis, and expert insights.
TRON USD Drops 0.97% Daily: TRXUSD at $0.3100
TRON USD drops 0.97% daily to $0.3100. Technical analysis shows oversold RSI at 32.32 with strong ADX trend at 46.34.
US and Iran Exchange Fire Over Downed Helicopter, June 10
US strikes Iranian targets after Apache helicopter downed; Iran retaliates with drone attacks over Strait of Hormuz.
Dogecoin USD Drops 1.34% Daily: DOGEUSD at $0.0846
DOGEUSD falls 1.34% to $0.0846. RSI at 33.94 signals oversold conditions. Technical analysis and price forecast inside.
Japan Boosts Defense Budget Plan to 3.5% of GDP, June 10
Japan’s LDP approves defense spending proposal targeting 3-3.5% of GDP. Government plans to finalize new security documents by December 2026.
Solana USD Bounces 1.28% Daily: SOLUSD at $71.94 Target
Solana USD trades at $64.27 with 1.28% daily bounce. Technical analysis shows oversold RSI at 29.24 and strong ADX trend at 28.73.
Wall Street Set for Higher Open as Investors Welcome Chip Rebound and Lower Iran-Israel Tensions
Wall Street looked set for a stronger opening as investors responded positively to a rebound in semiconductor stocks and signs of easing tensions between Iran and Israel. The improved mood across global financial markets helped lift futures tied to major U.S. indexes, reflecting growing optimism among traders and institutional investors. Market participants have been closely…
Hong Kong Civil Service Gets 2% Pay Rise, June 09
Hong Kong civil service receives 2% pay rise proposal. Unions worry about morale and recruitment as raise lags inflation.
TELUS Stock Falls 0.8% as Dividend Yield Attracts Income Investors, June 09
TELUS stock at C$17.04 offers 9.8% dividend yield with C$20.27 analyst target. Meyka rates B- citing high debt concerns.
Parabilis Medicines Targets Up to $2.3 Billion Valuation in Expanded U.S. IPO Amid Biotech Market Rally
Parabilis Medicines is aiming for a valuation of nearly $2.3 billion through an expanded U.S. initial public offering, highlighting renewed investor confidence in the biotechnology sector. The Cambridge, Massachusetts-based company increased the size of its offering as demand for biotech IPOs continues to improve following a challenging period for the industry. The company now plans…